Mood Disorders Clinical Trial
Official title:
Screening of Psychoactive Substances Use and Anxio-depressive Disorders in Consultation for HIV Pre-exposure Prophylaxis
HIV pre-exposure prophylaxis (PrEP) with Truvada®, a combination of two antiretrovirals (tenofovir & emtricitabine) is a prevention strategy for HIV-negative people at high risk of acquiring HIV. PrEP has thus been integrated as a new tool to significantly reduce the risk of HIV infection, especially among men who have sex with men (MSM). Since its introduction, an increase in sexually transmitted infections (STIs) has been observed, particularly in relation to the use of psychoactive substances in a sexual context (Chemsex). In this context, the description and evaluation of these practices seem necessary, as well as the impact on the risk of addiction and mental health.
Interventional, multi-center pilot study, including all subjects aged 18 years or older presenting in consultation for a PrEP renewal. The newsletter and a self-questionnaire will be systematically given in the waiting room to any PrEP consultant to evaluate the consumption of psychoactive substances (ASSIST questionnaire) and to identify anxio-depressive disorders (HAD questionnaire - Hospital Anxiety and Depression). scale). After consent, the answers will be discussed with the doctor during the consultation for appropriate care, including a referral to a psychiatrist and / or addictologist if necessary. The duration of the inclusions will be 6 months and the number of patients to include is 250. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05321602 -
Study to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder
|
Phase 1 | |
| Recruiting |
NCT05345392 -
Brain, Emotions, and Mind-Wandering
|
N/A | |
| Completed |
NCT05078450 -
Mood Lifters Online for Graduate Students and Young Professionals
|
N/A | |
| Not yet recruiting |
NCT04551027 -
Assessing the Effect of Compensatory Cognitive Intervention Among People With Severe Mental Illness
|
N/A | |
| Recruiting |
NCT03088657 -
Design and Methods of the Mood Disorder Cohort Research Consortium (MDCRC) Study
|
||
| Active, not recruiting |
NCT02542475 -
Low Field Magnetic Stimulation: Open Label Study.
|
Phase 1/Phase 2 | |
| Completed |
NCT00916552 -
Effects of Erythropoietin on Depressive Symptoms and Neurocognitive Deficits in Depression and Bipolar Disorder
|
Phase 2 | |
| Completed |
NCT00202514 -
Placebo Controlled Trial of Depakote ER in Alcohol Dependent Patients With Mood and/or Anxiety Symptoms
|
Phase 2/Phase 3 | |
| Completed |
NCT00217932 -
Effectiveness of Divalproex Sodium (Depakote) in Treating Children With Temper Outbursts and Severe Mood Swings
|
Phase 2 | |
| Completed |
NCT00006517 -
Clinical Trials of Three Non-Drug Treatments for Winter Depression (SAD)
|
N/A | |
| Terminated |
NCT03898843 -
Assisted Animal Therapy: ReAnimal
|
N/A | |
| Recruiting |
NCT04358900 -
Unobtrusive Monitoring of Affective Symptoms and Cognition Using Keyboard Dynamics (UnMASCK)
|
||
| Recruiting |
NCT06360562 -
Reconnecting to Ourselves and Others in Virtual Meetings (ROOM)
|
N/A | |
| Completed |
NCT05745103 -
Optimizing Behavioral Healthcare Delivery Through Technology
|
N/A | |
| Suspended |
NCT03715400 -
Mobile Virtual Positive Experiences for Anhedonia
|
N/A | |
| Enrolling by invitation |
NCT03736538 -
Nitrous Oxide- Suicidal Ideation
|
Phase 1 | |
| Completed |
NCT04601545 -
The Virtual Reality Therapy as a Pulmonary Rehabilitation Supporting Method
|
N/A | |
| Completed |
NCT02566980 -
Biological Triggers of Depression in Pregnancy
|
||
| Completed |
NCT03743844 -
Psychosocial Intervention for Women With Mood Disorders Seeking Treatment for Obesity
|
N/A | |
| Completed |
NCT05211063 -
Effects of CROCUVIS+® on Computer Vision Syndrome, Sleep and Mood Disorders
|
N/A |